News
XaQuil™XR with Quatrefolic® is the Finished Product of the Year
17 May 2016
Gnosis is proud to announce that its commitment to providing innovative solutions to global well-being and health care challenges has been rewarded at NutraIngredients Award 2016, winning in the FINISHED PRODUCT OF THE YEAR - medical food category with Xaquil™XR from Xymogen, a new finished product formulated with Quatrefolic®.
At Vitafoods, NutraIngredients Awards 2016 celebrated innovation and research of the global nutritional industry, awarding companies and products that, by seizing the most recent compelling nutritional needs, really bring tangible benefits to humans’ well-being.
XaQuil™XR, formulated with Quatrefolic® and developed through a fruitful partnership between XYMOGEN and Gnosis, triumphed as Finished Product of the Year in the Medical Food category.
The independent 10-person judging panel evaluated the true innovation, the validated research, and the ability to recognize and fill a gap in the health product sector. XaQuil™XR by Xymogen is an innovative medical food formulated with Quatrefolic®, and used as an adjunctive treatment for depression. XaQuil™XR fulfills the emergent scientific demand that has compelled psychiatrists to consider augmenting traditional antidepressants with the medical food L-methylfolate.
Quatrefolic® in XaQuil™XR is the glucosamine salt of the 5-methyltetrahydrofolate (5-MTHF), the metabolic active form of folate.
The specific & patented extended-release profile of Quatrefolic® was chosen in order to replicate what happens in the intestine to dietary folate.
The medical food industry is expanding and is driven by the rise in the aging population, the shift to enteral nutrition, and the demand for personalized medicine. Xaquil™XR offers the most bioavailable form of reduced folate available in the market, Quatrefolic®, the glucosamine salt of the 5-MTHF, in an innovative, orally-administered, extended-release formulation.
